This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Carna Biosciences, Inc., Sierra Oncology, Inc.. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: Bryan William Strouse: Innovator in Cancer Treatment
Introduction
Bryan William Strouse is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods.
Latest Patents
Strouse holds a patent for the invention titled "CHK1 (SRA737)/PARPi combination methods of inhibiting tumor growth." This patent discloses combinations of Checkpoint Kinase 1 (Chk1) inhibitors and PARP inhibitors that are useful for inhibiting the growth of tumors in cancer patients. The combination demonstrates remarkable synergistic effects on cancer cells that represent models for tumors. Additionally, the patent provides methods for treating disorders or diseases mediated or affected by Chk1 and/or PARP activity.
Career Highlights
Bryan William Strouse is currently associated with Sierra Oncology, Inc., where he continues to work on groundbreaking cancer therapies. His dedication to research and innovation has positioned him as a key figure in the fight against cancer.
Collaborations
Strouse has collaborated with notable colleagues, including Christian Andreus Hassig and Ryan Hansen, to advance cancer treatment methodologies.
Conclusion
Bryan William Strouse's contributions to cancer treatment through his innovative patent and collaborative efforts highlight his commitment to improving patient outcomes. His work exemplifies the impact of innovation in the medical field.